KORS, ADEP, SNSS - CRWESelect.com Stock News! Michael Kors Holdings Limited, Adept Technology, Sunesis Pharmaceuticals (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) February 14, 2012 -- To view video, and read the full article visit URL http://crweselect.com/28603/stock-alerts/kors-adep-snss-crweselectcom-stock-news-michael-kors-holdings-limited-adept-technology-sunesis-pharmaceuticals-video-included-inside/

Michael Kors Holdings Limited (NYSE: KORS)

Michael Kors Holdings Limited (KORS) announced today its financial results for the third quarter fiscal 2012 ended December 31, 2011. The Company's Total revenue for the third quarter increased 67.9% to $373.6 million from $222.5 million in the third quarter of fiscal 2011. For the fourth quarter of fiscal 2012, the Company expects total revenue to be in the range of $350 million to $355 million.

KORS is a world-renowned, award-winning designer of luxury accessories and ready to wear. His namesake company, established in 1981, currently produces a range of products through his Michael Kors, KORS Michael Kors and MICHAEL Michael Kors labels, including accessories, footwear, watches, jewelry, men’s and women’s ready to wear, and a full line of fragrance products. Michael Kors stores are located in some of the most prestigious cities in the world, including New York, Beverly Hills, Chicago, London, Milan, Paris, Munich, Istanbul, Dubai, Seoul, Tokyo and Hong Kong.

For more information about KORS please visit http://www.michaelkors.com

****

Adept Technology, Inc. (NASDAQ: ADEP)

Adept Technology, Inc. (ADEP) announced today it has received a $1.4 million order for high-precision robots from a major international manufacturer of sophisticated automation equipment for use in the consumer electronics and information technology industries. The order is expected to be fulfilled and recognized as revenue over the next two quarters. The company selected Adept as its automation partner to provide advanced robotic systems to be integrated into their process equipment as part of a program by their end-user manufacturer for increasing production capacities.

ADEP is a global, leading provider of intelligent robots and autonomous mobile solutions and services that enable customers to achieve precision, speed, quality and productivity in their assembly, handling, packaging, testing, and logistical processes. With a comprehensive portfolio of high-performance motion controllers, application development software, vision-guidance technology and high-reliability robot mechanisms with autonomous capabilities, Adept provides specialized, cost-effective robotics systems and services to high-growth markets including Packaging, Medical, Disk Drive/Electronics, and Solar; as well as to traditional industrial markets including machine tool automation and automotive components.

For more information about ADEP please visit http://www.adept.com

****

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

Sunesis Pharmaceuticals, Inc. (SNSS) announced today that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application No. 12/982,785 claiming certain compositions related to Sunesis' lead drug candidate, vosaroxin. The patent will grant Sunesis exclusive rights to certain Active Pharmaceutical Ingredient compositions of vosaroxin, as well as the final product related to such compositions, and provides patent exclusivity to mid 2030 in the United States. A family of corresponding patent applications are pending in the U.S. and internationally.

SNSS is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.

For more information about SNSS please visit http://www.sunesis.com

To read the full article visit URL http://crweselect.com/28603/stock-alerts/kors-adep-snss-crweselectcom-stock-news-michael-kors-holdings-limited-adept-technology-sunesis-pharmaceuticals-video-included-inside/

*****************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

KORScrweselect0214
ADEPcrweselect0214
SNSScrweselect0214

ADEP     Adept Technology     Kors     Michael Kors Holdings Limited     select     SNSS     Sunesis Pharmaceuticals     vosaroxin